Tag Archives: Diagnostic Testing

Earlier Diagnosis of Glaucoma – and Possibly Many Neurodegenerative Diseases – By Retinal Examination? (BBC News / NHS Choices / Brain)

Posted on May 1, 2017 by Dementia and Elderly Care News

Summary A fluorescent dye injected into the bloodstream may, in future, provide a convenient method of detecting glaucoma earlier – perhaps a decade before more overt symptoms and damage have had the opportunity to develop – by identifying changes in … Continue reading →

Posted in BBC News, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, NHS Digital (Previously NHS Choices), Parkinson's Disease, Quick Insights, UK, Universal Interest | Tagged Annexin 5 Labelled With Fluorescent Dye DY-776 (ANX776), ANX776 Pharmacokinetics and Pharmacodynamics, ANX776-Positive Fluorescent Cells, Apoptosis, Apoptotic Cells in Neurodegenerative Diseases, Apoptotic Neural Cell Death, Assessment and Diagnosis, BBC Health News, Behind the Headlines, Bethan Hughes: Wellcome Trust, Brain (Journal), Centre for Medical Image Computing: University College London, DARC: Detection of Apoptosing Retinal Cells, Dementia Diagnosis, Department of Visual Neuroscience: UCL Institute of Ophthalmology, Detection of Apoptosing Retinal Cells (DARC), Diagnostic Imaging, Diagnostic Markers, Diagnostic Testing, Drusen (Spots on Retina), Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Early Diagnosis of Parkinson’s Disease, Eye Cells, Eye Examinations, Glaucoma, Glaucoma and Retinal Neurodegeneration Group: UCL Institute of Ophthalmology, Glaucomatous Neurodegeneration, Imperial College London, Imperial College Ophthalmic Research Group (ICORG), Intravenous ANX776, Levels of Apoptosis (DARC Count), London, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neuronal Cell Apoptosis in Patients With Glaucoma, Neuronal Loss, Ocular Neurodegenerative Conditions, Potential of DARC as Surrogate Biomarker. Retinal Ganglion Cell Apoptosis, Retinal Assessments Using DARC (Detection of Apoptosing Retinal Cells), Retinal Cell Apoptosis, Retinal Ganglion Cell Layer, Retinal Nerve Fibre Layer (RNFL), Timely Diagnosis, Translational Imaging Group: University College London, UCL Institute of Ophthalmology, University College London, Western Eye Hospital, Western Eye Hospital: Imperial College Healthcare NHS Trust, Western Eye Hospital: Imperial College Healthcare NHS Trust (ICHNT) | Leave a comment

Skin Cells: A New Non-Invasive Biomarker? (BBC News / American Academy of Neurology)

Posted on March 2, 2015 by Dementia and Elderly Care News

Summary Skin may be a good candidate biomarker for detecting hidden brain disorders earlier. Abnormal proteins which accumulate in the brain in neurodegenerative disorders such as Alzheimer’s Disease and Parkinson’s Disease can be found in the skin too. Research is … Continue reading →

Posted in BBC News, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Parkinson's Disease, Quick Insights, Universal Interest | Tagged Abnormal Proteins, Abnormal Proteins (Alpha-Synuclein), Abnormal Proteins (Tau), Alzheimer's Disease: Diagnosis, American Academy of Neurology, American Academy of Neurology’s 67th Annual Meeting (Washington 2015), Assessment and Diagnosis, BBC Health News, Biomarkers, Central Hospital at the University of San Luis Potosi, Dementia Diagnosis, Diagnostic Markers, Diagnostic Testing, Differential Diagnosis, Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Early Differential Diagnosis, α-Synuclein, α-Synuclein Aggregation, Mexico, National Council of Science and Technology of Mexico, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Non-Invasive Biomarkers, Parkinson’s Disease Diagnosis, Parkinsonism, Post-Mortem Studies, Skin Biopsies, Skin Cells, Skin Tests, Synucleinopathy, Tau, Tau Pathology, Tau Protein, Timely Diagnosis, University of San Luis Potosi (Mexico) | Leave a comment

Promoting Awareness of Current Trials and Encouraging Public Engagement in Dementia Research (NIHR / Join Dementia Research)

Posted on December 30, 2014 by Dementia and Elderly Care News

Summary The “Join Dementia Research” website has been designed to assist people to learn more about dementia research which is ongoing, whether in their local areas or across the UK. This service offers the public opportunities to get involved in … Continue reading →

Posted in Alzheimer's Society, Alzheimer’s Research UK, Charitable Bodies, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Social Workers (mostly), Local Interest, Management of Condition, Models of Dementia Care, National, NIHR, Non-Pharmacological Treatments, Northern Ireland, Parkinson's Disease, Patient Care Pathway, Patient Information, Pharmacological Treatments, Practical Advice, Quick Insights, UK, Universal Interest, Wales | Tagged 24 Days of Dementia Research: Advent Calendar 2014, Advent Calendar: 24 Days of Dementia Research (2014), AFFECT Study, Ageing, Ageing and Dementia, Amlodipine, Amyloid and Tau Imaging, Amyloid Beta, Amyloid Imaging, Amyloid Proteins, Amyloid-β (Aβ), “GE180” Study, Bangor University, Behavioural Frontotemporal Dementia (bvFTD), Behavioural Variant Frontotemporal Dementia (bvFTD), Beta-Amyloid, Beta-Amyloid Plaques, Biomarkers, Brain Beta Amyloid Load, Cognitive Rehabilitation, Cognitive Rehabilitation Therapies (CRTs), Cognitive Rehabilitation Therapy, DAPA - Dementia and Physical Activity Trial, DAPA Study, Dementia Research, Dementia Research Centre (DRC) at University College London, Dementia Research Centre: University College London, Dementia Risk Prevention, Dementias and neurodegeneration (DeNDRoN) Specialty, Dementias and Neurodegenerative Diseases Research Network (DeNDRoN), DeNDRoN: Dementias and Neurodegenerative Diseases Research Network, Diagnostic Testing, Down Syndrome, Dr Tamara Al-Janabi: University College London, Early-Onset Dementia, Environmental and Lifestyle Factors, Environmental Hazards, Environmental Issues, Epidemiology, Exercise, Exercise And Lifestyle For Older People, Exercise for Dementia, Exercise Medicine, Exercise Therapy, GE180, GE180 Tracer / Marker, Genetic Triggers, Genetics, Goal-Oriented Cognitive Rehabilitation in Early-Stage Alzheimer's Disease Trial (GREAT), GREAT Study: Goal-Oriented Cognitive Rehabilitation in EArly sTage Dementia, GREAT: Goal-Oriented Cognitive Rehabilitation in Early-Stage Alzheimer's Disease Trial, IDEAL Project, IDEAL Project: Research in Ageing and Cognitive Health at Bangor University, IDEAL Study, Imperial College London, Improving the Experience of Dementia and Enhancing Active Life (IDEAL), Inflammation, Institute of Psychiatry at King’s College London, Institute of Psychiatry: King's College London, Join Dementia Research, Join Dementia Research National Service, Join Dementia Research: Recruitment Onto Dementia Studies, Kings College London, Leuco-Methylthioninium (LMTM), Living Well with Dementia, Living Well With Memory Difficulties’ (GREAT Study), London Down Syndrome Consortium (LonDownS), MCI: Mild Cognitive Impairment, Mild Cognitive Impairment (MCI), National Institute for Health Research (NIHR), Neuroinflammation, Neuroinflammation and Amyloid Study, NIHR: National Institute for Health Research, Non-Invasive Biomarkers, Participation in Research, Participation in Research Studies, Patient Involvement in Research, Patient Participation Groups, Patient Participation Groups (PPGs), Physical Activity, Physical Activity Programmes, Physical Exercise, Practice Participation Groups, Pre-Dementia (MCI), PREVENT Study, Prevention, Prevention of Vascular Dementia, Professor Simon Lovestone: King’s College London’s Department of Old Age Psychiatry, Prophylaxis, PROTECT Study, Public Health, Public Involvement in Research, Public Participation in Research, Regular Exercise, Research Engagement and Involvement Activities, Science of Ageing, Subcortical Ischemic Vascular Dementia (SIVD), Subcortical Vascular Dementia, Talking Therapies, University College London, University College London (UCL), University of Warwick, University of Warwick Medical School, Vascular Dementia: Prevention, Warwick Medical School: University of Warwick, Young Onset Alzheimer’s Disease (YOAD) Study, Young Onset Dementia (YOD), Young-Onset Dementia | Leave a comment

Dementia Diagnosis and Prediction Using Eye Examinations? (BBC News)

Posted on October 27, 2014 by Dementia and Elderly Care News

Summary A £1.1m three year study involving researchers from Dundee University and Edinburgh will investigate whether eye tests can aid non-invasive diagnosis by providing an “early warning” of Alzheimer’s Disease and other conditions. It is thought that changes in the eye … Continue reading →

Posted in BBC News, Diagnosis, For Researchers (mostly), In the News, Quick Insights, Scotland, UK, Universal Interest | Tagged Alzheimer's Disease: Diagnosis, Assessment and Diagnosis, BBC Health News, BBC Tayside and Central Scotland, Dementia Diagnosis, Diagnostic Markers, Diagnostic Testing, Differential Diagnosis, Drusen (Spots on Retina), Dundee, Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Edinburgh, Engineering and Physical Sciences Research Council (EPSRC), EPSRC: Engineering and Physical Sciences Research Council, Eye Cells, Eye Examinations, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neuronal Loss, Ninewells Hospital, Non-Invasive Biomarkers, Optomap Screening Test, Optos (Retinal Imaging Company), Retinal Ganglion Cell Layer, Retinal Inner Nuclear Layer, Retinal Neuronal Loss, Timely Diagnosis, University of Dundee | Leave a comment

Weekend Hospital Care: Seven-Day Working (BBC News / NHS England / HEE / GMC)

Posted on December 15, 2013 by Dementia and Elderly Care News

Summary NHS England medical director Professor Sir Bruce Keogh has announced that hospitals in England will be required to ensure consultants and key diagnostic tests are available seven days a week. Research into the “weekend effect” has suggested for some years that hospital mortality … Continue reading →

Future Dementia Diagnosis or Prediction Via Eye Examinations? (BBC News / US Society for Neuroscience Conference)

Posted on November 14, 2013 by Dementia and Elderly Care News

Summary The retina is a direct extension of the brain. Early research has discovered that mice genetically engineered to have a version of Alzheimer’s Disease show a corresponding loss thickness in a layer of specific cells in the retina, and … Continue reading →

Posted in BBC News, Diagnosis, For Researchers (mostly), In the News, International, Patient Care Pathway, Quick Insights, Universal Interest | Tagged Alzheimer's Disease: Diagnosis, Assessment and Diagnosis, BBC Health News, Commercial Tests for Alzheimer's Disease, Dementia Diagnosis, Diagnosis and Referral, Diagnostic Markers, Diagnostic Testing, Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Eye Cells, Eye Examinations, Georgetown University Medical Center, Georgetown University Medical Center (GUMC), Mouse Model of Alzheimer's Disease, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neuronal Loss, Retinal Ganglion Cell Layer, Retinal Inner Nuclear Layer, Retinal Neuronal Loss, Society for Neuroscience, Timely Diagnosis, Transgenic Mice, United States, US Society for Neuroscience Conference, USA | Leave a comment

Recent Systematic Reviews and Meta-Analyses on Diagnosis, Screening, Assessment and Symptoms

Posted on October 17, 2013 by Dementia and Elderly Care News

Some of the following articles are available freely, while the full-text of the other articles may need a suitable Athens password, a journal subscription or payment for access. The Bibliographic Citations Defina, P.A. Moser, R.S. Glenn, M. [et al]. (2013). … Continue reading →

Posted in Diagnosis, For Doctors (mostly), For Researchers (mostly), International, Systematic Reviews | Tagged Alzheimer's Disease: Diagnosis, Assessment and Diagnosis, Assessment Instruments for Dementia, Blood Oxygen Level-Dependent fMRI Data, Clinical Research Institute: National University of Colombia, Dementia Diagnosis, Dementia Screening, Department of Clinical Radiology: University Hospital Münster, Diagnosis and Assessment, Diagnostic Testing, Disclosure, Disclosure of Diagnosis, Grupo de Evaluación de Tecnologías y Políticas en Salud: National University of Colombia, HIV-Associated Neurocognitive Disorders, Hospital General Universitario de Alicante, Human Immunodeficiency Virus (HIV)-Associated Neurocognitive Disorder (HAND), International Brain Research Foundation Inc.: USA, Mind Exchange Program, Mind Exchange Working Group, National University of Colombia, School of Medicine: National University of Colombia, Selected Systematic Reviews and Meta-Analyses, Servicio de Neurología: Hospital General Universitario de Alicante, Systematic Reviews and Meta-Analyses, Truth Telling, University Hospital Münster, University of Cologne, University of Haifa, University of Vienna | Leave a comment

Tag Archives: Diagnostic Testing

Earlier Diagnosis of Glaucoma – and Possibly Many Neurodegenerative Diseases – By Retinal Examination? (BBC News / NHS Choices / Brain)

Skin Cells: A New Non-Invasive Biomarker? (BBC News / American Academy of Neurology)

Dementia Diagnosis and Prediction Using Eye Examinations? (BBC News)

Future Dementia Diagnosis or Prediction Via Eye Examinations? (BBC News / US Society for Neuroscience Conference)

Recent Systematic Reviews and Meta-Analyses on Diagnosis, Screening, Assessment and Symptoms

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites